Investors in InMode Ltd. INMD need to pay close attention to the stock based on moves in the options market lately. That is because the Feb. 21, 2025 $10.00 Put had some of the highest implied ...

InMode (INMD) has just issued fresh revenue guidance, outlining expectations of US$103.6 million to US$103.8 million for Q4 ...

Wall Street expects a year-over-year increase in earnings on higher revenues when InMode (INMD) reports results for the quarter ended June 2025. While this widely-known consensus outlook is important ...

Despite a highly profitable business model and a strong position in the medical aesthetics industry, INMD stock is down -33% over the last 12 months. Macroeconomic pressures, political risks in InMode ...

Despite INMD being down -22% since I recommended to Buy the stock in March, InMode Ltd. remains a highly profitable & innovative leader in the aesthetic industry. Stronger than expected macroeconomic ...

InMode (INMD) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to ...

Inmode ( (INMD)) has released its Q3 earnings. Here is a breakdown of the information Inmode presented to its investors. InMode Ltd. is a global provider of innovative medical technologies, ...

Investing in stocks inevitably means buying into some companies that perform poorly. Long term InMode Ltd. (NASDAQ:INMD) shareholders know that all too well, since the share price is down considerably ...

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable ...